
Cancer caregivers with high depression symptoms are twice as likely to experience declining health.

Cancer caregivers with high depression symptoms are twice as likely to experience declining health.

The National Association of Specialty Pharmacy expresses concern about fraud driving escalating drug costs.

Issues surrounding patents for curative drugs allow pharmaceutical companies to establish a market monopoly and charge astronomical prices.

The risk of gallbladder cancer was highest in women with a history of periodontal disease.

Four doses of PrEP around the time of sexual activity reduced HIV-infection risk by 97%.

Top news of the day from across the health care landscape.

Studying HER2-positive breast cancer at the cellular level may yield new treatments.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.

An estimated 2.7 million Americans have hepatitis C, too many for specialists to be the sole provider of anti-HCV therapy.

Pharmacy law conference, specialty certification exam prep course, and women in specialty luncheon highlight annual meeting and expo.

The upcoming National Association of Specialty Pharmacy annual meeting has unique offerings for attendees.

Naloxegol approved to treat opioid-induced constipation in patients with pain from previous treatment for cancer.

Housing Opportunities for Persons With AIDS program awarded $320.4 million to qualifying states and local jurisdictions.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Top news of the day from across the health care landscape.

Study findings highlight the importance of community-based health interventions that target cancer prevention.

Repatha combined with statin therapy may reduce cardiovascular events.

The launch of a second Remicade biosimilar could open the floodgates to biosimilar competition in the specialty drug market.

Approval sought for vemurafenib (Zelboraf) to treat Erdheim-Chester disease with BRAF V600 mutation.

Physical training further minimizes brain shrinkage in MS patients already receiving medication.

Brandon Shank, PharmD, MPH, BCOP, discusses the role of the oncology pharmacist in providing consultation and maintaining communication with cancer patients during treatment.

Partner violence negatively impacts the ability of women with HIV to adhere to antiretrovirals.

Top news of the day from across the health care landscape.

Patients with chronic obstructive pulmonary disease often have difficulty adhering to medications, which can lead to hospitalization.

Rebecca Shanahan, JD, chief executive officer of Avella Specialty and president of the National Association of Specialty Pharmacy discusses how legislation can impact direct and indirect remuneration fees.

National Association of Specialty Pharmacy states that direct and indirect remuneration fees increase drug costs for seniors.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the importance of specialty pharmacists in a patient-centric environment.

Heplisav-B aims to boost a patient’s own immune response to fight off HBV.

Two mutations may cause angioimmunoblastic T cell lymphoma.

Top news of the day from across the health care landscape.